• 123852 Citations
  • 160 h-Index
1958 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Scott M Grundy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 45 Similar Profiles
Cholesterol Medicine & Life Sciences
Coronary Disease Medicine & Life Sciences
Lipoproteins Medicine & Life Sciences
LDL Lipoproteins Medicine & Life Sciences
LDL Cholesterol Medicine & Life Sciences
Hypercholesterolemia Medicine & Life Sciences
Triglycerides Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1958 2019

3 Citations (Scopus)
Secondary Prevention
Patient Advocacy
Physician Assistants
Primary Prevention
Open Access
LDL Cholesterol
Cardiovascular Diseases
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Professional Education
2 Citations (Scopus)

Elevated apolipoprotein B as a risk-enhancing factor in 2018 cholesterol guidelines

Grundy, S. M. & Stone, N. J., May 1 2019, In : Journal of Clinical Lipidology. 13, 3, p. 356-359 4 p.

Research output: Contribution to journalEditorial

Apolipoproteins B

Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol

Chuzi, S., Pfenniger, A., Lloyd-Jones, D. M., Blumenthal, R. S., Smith, S. C., Virani, S. S., Grundy, S. M. & Stone, N. J., Jan 1 2019, In : JAMA Cardiology.

Research output: Contribution to journalArticle

Case Management
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hyperlipoproteinemia Type II